![Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric site | eLife Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric site | eLife](https://iiif.elifesciences.org/lax/56519%2Felife-56519-fig1-v2.tif/full/,1500/0/default.jpg)
Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric site | eLife
![Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA) Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)](https://nida.nih.gov/sites/default/files/images/valenza_zamarripa_fig_3.gif)
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
![Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor: Trends in Pharmacological Sciences Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor: Trends in Pharmacological Sciences](https://www.cell.com/cms/attachment/80bba834-8503-46c6-baf2-4d337398fb85/gr1.jpg)
Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor: Trends in Pharmacological Sciences
Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids | PLOS ONE
![Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA) Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)](https://nida.nih.gov/sites/default/files/styles/content_image_medium/public/images/valenza_zamarripa_promo.jpg?itok=HRbtRBEw)
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
![Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists](https://www.frontiersin.org/files/Articles/447554/fphar-10-00407-HTML/image_m/fphar-10-00407-g001.jpg)
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
![Pharmaceutics | Free Full-Text | Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism Pharmaceutics | Free Full-Text | Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism](https://www.mdpi.com/pharmaceutics/pharmaceutics-13-01466/article_deploy/html/images/pharmaceutics-13-01466-g001.png)
Pharmaceutics | Free Full-Text | Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism
![A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523422006870-ga1.jpg)
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
![Does the pharmacology of oxycodone justify its increasing use as an analgesic?: Trends in Pharmacological Sciences Does the pharmacology of oxycodone justify its increasing use as an analgesic?: Trends in Pharmacological Sciences](https://www.cell.com/cms/attachment/baed76eb-3e38-4f78-aded-c6afefdd84a0/gr1.jpg)
Does the pharmacology of oxycodone justify its increasing use as an analgesic?: Trends in Pharmacological Sciences
![N-Phenethyl Substitution in 14-Methoxy-N-methylmorphinan-6-ones Turns Selective µ Opioid Receptor Ligands into Dual µ/δ Opioid Receptor Agonists | Scientific Reports N-Phenethyl Substitution in 14-Methoxy-N-methylmorphinan-6-ones Turns Selective µ Opioid Receptor Ligands into Dual µ/δ Opioid Receptor Agonists | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-62530-w/MediaObjects/41598_2020_62530_Fig1_HTML.png)
N-Phenethyl Substitution in 14-Methoxy-N-methylmorphinan-6-ones Turns Selective µ Opioid Receptor Ligands into Dual µ/δ Opioid Receptor Agonists | Scientific Reports
![Antioxidants | Free Full-Text | Opioids and Vitamin C: Known Interactions and Potential for Redox-Signaling Crosstalk Antioxidants | Free Full-Text | Opioids and Vitamin C: Known Interactions and Potential for Redox-Signaling Crosstalk](https://pub.mdpi-res.com/antioxidants/antioxidants-11-01267/article_deploy/html/images/antioxidants-11-01267-g001.png?1656328677)